Muscle Aging Science & Translation Symposium

The Muscle Aging Science and Translation (MAST) Symposium took place on April 18th, 2024 and featured over 400 participants. It was the largest Aging Initiative event to date, bringing together academic, clinical research, biotech, pharma, exercise science and other multidisciplinary experts together to share the frontiers of muscle preservation and frailty prevention. We are excited to announce the Neuroscience of Vitality and Aging (NOVA) Symposium as our next grand event in Spring 2026, which will bring together near 1000 participants.

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Amet minim mollit non deserunt

Age-related frailty, including sarcopenia, osteoarthritis, and hip fractures, threatens mobility, independence, and quality of life. Despite their prevalence, there are no approved treatments for sarcopenia or muscle preservation during bed rest or hip fracture recovery, and disease-modifying therapies for osteoarthritis remain elusive. With aging populations worldwide, the need for innovation in treatment strategies and clinical development is urgent. This conference brings together researchers and students to discuss emerging solutions and drive collaboration in the fight against muscle aging.

April 18th 2024, 2025 3:00 – 7:00 pm @ Joseph B. Martin Conference Center

Panel Session #1: Opening Talks: A Clinical Research Perspective on Frailty
‍

Roger Fielding, PhD

Professor of Medicine, Tufts University School of Medicine

Douglas Kiel, MD, MPH

Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center

Shivani Sahni, PhD

Associate Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center

Yi-Hsiang Hsu, MD, ScD

Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center

Flash Talk: Next Generation Therapeutic Approaches

Lada Nuzhna

Founder and Chief Executive Officer, Stealth Biotechnology Company; Director, Impetus Grants

Flash Talk: In Vivo Pooled Screening for Translational Discovery in Osteoarthritis

Francisco LePort, PhD

Co-Founder and Chief Executive Officer, Gordian Biotechnology

Panel #2: Biotech & Drug Development for Muscle Aging

David Glass, MD

Vice President, Research, Aging and Age-Related Disorders, Regeneron

Anne Ulrike-Trendelenburg, PhD

Director, Diseases of Aging and Regenerative Medicine, Novartis

Andrew Adams, PhD

Group Vice President, Molecule Discovery and Director, Institute of Genetic Medicines, Eli Lilly and Company

Ken Attie, MD

Vice President, Clinical Research, Obesity, Eli Lilly and Company; Chief Medical Officer, Versanis Bio

Panel #3: Exercise Science for Muscle Longevity

Brad Schoenfeld, PhD

Professor of Exercise Science, Lehman College

Jeff Nippard, PhD

Professional Bodybuilder; Science Communicator

Thank You to Our Sponsors